A global immune deficit in Alzheimer's Disease and Mild Cognitive Impairment disclosed by a novel data mining process

Manuscript Number: 

14-1116R2

Author(s): 
Margherita Alberoni, Bruno Borgiani, Massimo Buscema, Gian Pietro Comi, Cristina Cursano, Elisabetta Farina, Roberto Furlan, Maira Gironi, Enzo Grossi, Enrica Mariani, Raffaello Nemni

Disclosures

Margherita Alberoni

  • Nothing to Disclose

Bruno Borgiani

  • Nothing to Disclose

Massimo Buscema

  • Nothing to Disclose

Gian Pietro Comi

  • Consulting Fees:
    Paid Scientific board from Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi-Aventis, Merck Serono, Bayer Schering, Actelion and Geneuro and lecture fees from Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi-Aventis, Merck Serono, Biogen Domp?, Bayer Schering and Serono Symposia International Foundation.
    Lecture Fees:
    from Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi-Aventis, Merck Serono, Bayer Schering, Actelion and Geneuro and lecture fees from Novartis, Teva Pharmaceutical Ind. Ltd, Sanofi-Aventis, Merck Serono, Biogen Domp?, Bayer Schering and Serono Symposia

Cristina Cursano

  • Nothing to Disclose

Elisabetta Farina

  • Nothing to Disclose

Roberto Furlan

  • Lecture Fees:
    from Novartis, Merck Serono, Biogen

Maira Gironi

  • Lecture Fees:
    Biogen Merck-Serono

Enzo Grossi

  • Nothing to Disclose

Enrica Mariani

  • Nothing to Disclose

Raffaello Nemni

  • Nothing to Disclose